Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-04-02 16:36:21 ET · period of report 2026-04-02 · accession 0001231589-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-02 16:36 | 2026-04-02 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-04-02 16:36 | 2026-04-02 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $565.87 | -8,300 | 45.2K | -16% | -$4.70M |
| DT | 2026-04-02 16:36 | 2026-04-02 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -8,300 | 16.9K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-02 | M | A | 8,300 | $146.03 | 53,472 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 2 | Common | Common Stock | 2026-04-02 | S | D | 514 | $560.30 | 52,958 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $559.83 to $560.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-04-02 | S | D | 351 | $561.69 | 52,607 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $560.885 to $561.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-04-02 | S | D | 774 | $562.34 | 51,833 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $562.00 to $562.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-04-02 | S | D | 371 | $563.58 | 51,462 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $563.03 to $564.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-04-02 | S | D | 1,115 | $564.55 | 50,347 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $564.09 to $565.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-04-02 | S | D | 543 | $565.66 | 49,804 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $565.09 to $566.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-04-02 | S | D | 1,629 | $566.66 | 48,175 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F8) This transaction was executed in multiple trades at prices ranging from $566.12 to $567.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2026-04-02 | S | D | 1,403 | $567.55 | 46,772 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F9) This transaction was executed in multiple trades at prices ranging from $567.17 to $568.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2026-04-02 | S | D | 690 | $568.79 | 46,082 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F10) This transaction was executed in multiple trades at prices ranging from $568.17 to $569.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Common | Common Stock | 2026-04-02 | S | D | 710 | $569.61 | 45,372 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F11) This transaction was executed in multiple trades at prices ranging from $569.485 to $569.775. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 12 | Common | Common Stock | 2026-04-02 | S | D | 200 | $571.61 | 45,172 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F12) This transaction was executed in multiple trades at prices ranging from $571.53 to $571.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 13 | Derivative | Stock Option | 2026-04-02 | M | D | 8,300 | $0.00 | 16,900 | D | $146.03 · 2020-03-15 to 2027-03-15 | 8,300 Common Stock | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |